ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2020

First-in-Humans Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted PET.

Simone Krebs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.